PANACEA BIOTEC LTD. - 531349 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Please find attached certificate dated July 02, 2024 issued by Skyline Financial Services Pvt. Ltd., Registrar and Transfer Agent of the Company, confirming compliance under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for quarter ended June, 2024. PANACEA BIOTEC LTD. - 531349 - Demat Status Report For The Month Of June, 2024
Please find attached details of shares dematerialized during June, 2024 under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 PANACEA BIOTEC LTD. - 531349 - Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
This is to inform you that NSE and BSE Ltd. have, vide their notice / email dated July 01, 2024, imposed a fine of Rs.11,800 each (inclusive of GST) for non-compliance with the provisions of Regulation 29(2)/29(3) of SEBI LODR Regulations. The detailed disclosure pursuant to SEBI Circular dated July 13, 2023 is attached herewith. PANACEA BIOTEC LTD. - 531349 - Disclosure Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015
We would like to inform you that the Company has received today, a copy of Request for Arbitration filed by Human Vaccine Limited Liability Company, Russia with London court of International Arbitration of dispute between the parties. The details of the said arbitration in the specified format as per the said SEBI Circular is annexed herewith. PANACEA BIOTEC LTD. - 531349 - Closure of Trading Window
We would like to inform you that the trading window of the Company shall remain closed for all Designated Persons of the Company from July 01, 2024 till completion of 48 hours from the announcement of the unaudited financial results of the Company for quarter ending June 30, 2024 to the Stock Exchanges. PANACEA BIOTEC LTD. - 531349 - Intimation Regarding Change In Senior Management Personnel Of The Company'S Material Subsidiary Viz. Panacea Biotec Pharma Limited
We would like to inform you that Dr. Shekhar Patel who was working as Chief Executive Officer - US Business of the Company''s material subsidiary, Panacea Biotec Pharma Ltd., has been appointed as Chief Executive Officer of Panacea Biotec Inc. w.e.f. June 26, 2024 and has ceased to be Senior Management Personnel of PBPL at the end of the day on June 25, 2024. PANACEA BIOTEC LTD. - 531349 - Intimation Of Incorporation Of Step-Down Subsidiary Company
We would like to inform you that the Company''s material subsidiary, Panacea Biotec Pharma Ltd. has incorporated its wholly owned subsidiary company namely, Panacea Biotec Inc. in the state of Delaware, USA and has made an initial investment of US$75,000 (~Rs.6.23 million) in the shares of common stock of Panacea Biotec Inc. PANACEA BIOTEC LTD. - 531349 - Demat Status Report For The Month Of May, 2024
We would like to inform you that no share has been dematerialised during the month of May, 2024. A copy of the certificate obtained from the Company''s RTA regarding shares dematerialised as on May 31, 2024 is enclosed herewith. PANACEA BIOTEC LTD. - 531349 - Re-Designation Of Mr. Ankesh Jain As Whole-Time Director In The Company And Its Wholly Owned Subsidiary, Panacea Biotec Pharma Limited
The Board in its meeting held on 30.05.2024 approved the re-designation of Mr. Ankesh Jain from Whole-time director designated as Director Sales & Marketing to Whole-time Director of the Company for the remaining tenure of his Term i.e. from 01.06.2024 to 31.03.2025. The Board of Directors of the Company''s wholly owned subsidiary company, Panacea Biotec Pharma Ltd. has also re-designated Mr. Ankesh Jain who is currently acting as its non-executive Director, to the position of Whole-time Director w.e.f. 01.06.2024. Mr. Ankesh Jain is not debarred from holding the office of Whole-time director in the Company as well as Panacea Biotec Pharma Ltd, by virtue of SEBI order or any other such authority PANACEA BIOTEC LTD. - 531349 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Please find enclosed herewith newspaper copies of the Extract of Statement of the Audited Financial Results for the quarter and financial year ended March 31, 2024, published in the newspapers on May 31, 2024.